Related Experiment Video
Updated: Feb 9, 2026

Using Primary Neurosphere Cultures to Study Primary Cilia
Published on: April 14, 2017
The Use of Denosumab in a Nonagenarian with Primary Hyperparathyroidism
Tamer Shalaby1, Samantha Anandappa2, Siva Sivappriyan3
1Registrar in Acute Medicine and Endocrinology.
Abstract:
Denosumab is a monoclonal antibody which is currently licensed in the UK drug market for the prevention of skeletal-related events secondary to malignancy (excluding myeloma). This monoclonal antibody is a 6 monthly subcutaneous injection that works by lowering calcium levels. When used in a 90 year old patient with primary hyperparathyroidism it demonstrated a dramatic reduction in the calcium level which had proven difficult to reduce by bisphosphonates and who was not a candidate for surgical intervention.
Related Concept Videos
Primary Active Transport
Primary Active Transport
Primary and Secondary Growth in Roots and Shoots
Primary Production
Primary Distribution
Nomenclature of Primary Amines

